Lantheus Holdings Stock News

Lantheus Holdings Inc (NASDAQ:LNTH) Director Julie Mchugh sold 1,756 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $15.86,

Los Angeles Capital Management & Equity Research Inc. grew its position in Lantheus Holdings Inc (NASDAQ:LNTH) by 13.1% in the 4th quarter, according to its most recent filing with the SEC. The firm o

Lantheus Holdings Inc (NASDAQ:LNTH) CEO Mary Anne Heino sold 6,615 shares of the firm’s stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.09, for a to

Lantheus Holdings Inc (NASDAQ:LNTH) reached a new 52-week low during mid-day trading on Friday after an insider sold shares in the company. The company traded as low as $15.49 and last traded at $15.5

LSV Asset Management reduced its holdings in shares of Lantheus Holdings Inc (NASDAQ:LNTH) by 2.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commissi

Lantheus Holdings Inc (NASDAQ:LNTH) CEO Mary Anne Heino sold 9,898 shares of Lantheus stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $16.06, f

Q4 2019 Lantheus Holdings Inc Earnings Call

Q4 2019 Lantheus Holdings Inc Earnings Call

Last week saw the newest full-year earnings release from Lantheus Holdings, Inc. (NASDAQ:LNTH), an important milestone...

Lantheus Holdings, Inc. (NASDAQ:LNTH) last week reported its latest yearly results, which makes it a good time for...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 25) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) (Cowen

Lantheus (NASDAQ:LNTH) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Wednesday, BidAskClub reports. Separately, ValuEngine

Merger activity increased with five new deals announced. The acquisition of E*Trade by Morgan Stanley. Progenics Pharmaceuticals enters into an amended and rest

Lantheus Holding, Inc. (NASDAQ:LNTH) Q4 2019 Results Earnings Conference Call February 25, 2020, 08:00 AM ET Company Participants Mark Kinarney - Director, Inve

LNTH earnings call for the period ending December 31, 2019.